The human milk oligosaccharides market is anticipated to expand at a CAGR of 22.7% during the anticipated time frame. According to projections, the market would be worth US$ 1,539.21Mn by 2032, up from US$ 199.0Mn in 2022.
The market for human milk oligosaccharides (HMOs) is growing quickly as more individuals become aware of their health advantages. Breast milk contains complex carbohydrates that are crucial for a baby’s immune system and digestive health. The sector is moving forward thanks to expanding research, technological advancements, and rising demand for functional additives.
According to WHO, the total world population is estimated to increase by approximately one billion in the next 10 years and will reach 9.5 billion by 2050. Incidentally, demand has been relatively higher than the supply of infant nutrition products. Meanwhile, sales of infant formula are also surging in some Asian countries such as China and India, promoting the consumption of HMOs alike. Future Market Insights’ latest report reveals that the global human milk oligosaccharides market is set to surpass a valuation of US$ 76 Mn, registering a CAGR of 22.7% between 2022 and 2032. This growth will be primarily orchestrated by the increasing application of HMO in infant nutrition products.
Discover the Power of Knowledge! Get our Report Sample Now and Elevate Your Understanding.@
https://www.futuremarketinsights.com/reports/sample/rep-gb-4252
In 2017 and beyond, the human milk oligosaccharides market in Europe is anticipated to witness significant revenue growth. Towards the end of 2027, Europe is anticipated to account for over 49% value share of the global market. Manufacturers in Europe are filing claims for regulatory approvals and product safety certifications in order to use HMO for preparing infant formulas. In North America, the HMO market is currently valued at over US$ 6 Mn and holds the second spot in terms of market size after Europe.
FMI’s report, titled “Human Milk Oligosaccharides Market Global Industry Analysis and Opportunity Assessment, 2017 – 2027” also cites that demand for HMO is gaining traction due to a positive perception of its prebiotic properties that help maintain a healthy immune system in infants. In addition, manufacturers are focusing on increasing their production capacities in order to enhance production of HMOs such as 2’-FL (2-fucosyllactose) that can be potentially used as an ingredient in functional food and beverages. zuChem Inc., Glycosyn LLC, Elicityl SA, Jennewein Biotechnologie GmbH, Glycom A/S, Dextra Laboratories Limited, Carbosynth Limited, Inbiose NV, ProZyme, Inc. are the leading companies operating in the global human milk oligosaccharides market.
Key Excerpts of the Report Include:
- Among product type, fucosyllactose HMO currently accounts for the largest value share of the market followed by sialyllactose HMO. However, the latter is expected to register a faster growth rate in terms of the market value over the forecast period.
- By 2017-end, US$ 5.5 Mn worth sialyllactose HMO is expected to be consumed globally.
- Increasing demand for functional food and beverage products is projected to further facilitate the growth of global human milk oligosaccharides market over the next couple of years.
Market Segmentation
By Product Type
- Fucosyllactose
- LNT & LNnT
- Sialyllactose
By Region
- North America
- Europe
- Asia Pacific
Lift the Veil on Our Methodological Excellence @ https://www.futuremarketinsights.com/request-report-methodology/rep-gb-4252
Frequently Asked Questions
- How big is the Human Milk Oligosaccharides Market?
- At What Rate is Human Milk Oligosaccharides Market expected to rise?
- What is the North America, Human Milk Oligosaccharides Market Outlook?
- Which are the major countries driving demand for Human Milk Oligosaccharides Market?
- At what rate will the China Human Milk Oligosaccharides Market grow?
- At what rate will the Germany Human Milk Oligosaccharides Market grow?
- At What Rate will, Human Milk Oligosaccharides Market Demand Grow in Europe?
- Who are the top 5 players operating in the market?
- At what rate will the Mexico Human Milk Oligosaccharides Market grow?
- What is the outlook forecast for the Human Milk Oligosaccharides Market?
Human Milk Oligosaccharides Market by Category
By Product Type, Human Milk Oligosaccharides Market is Segmented as:
- Fucosyllactose
- LNT & LNnT
- Sialyllactose
By Region Human Milk Oligosaccharides Market is Segmented as:
- North America
- Europe
- Asia Pacific
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
